Physician

Mikhail I Shtivelband, MD

According to 2025 Medicare claims, Mikhail Shtivelband, MD (NPI: 1740254473) practices hematology/oncology in the Phoenix-Mesa-Chandler, AZ market, with the plurality of this provider's patient population coming from Maricopa, AZ. This provider's primary affiliated billing organization is IRONWOOD PHYSICIANS, PC (NPI: 1740269299; TIN: 731636831) and primary practice location at 85224-5665. Shtivelband is affiliated with the Arizona Care Network (ACO ID: A5176) and Commonwealth Primary Care ACO LLC (ACO ID: D0224), participating under both the MSSP and REACH models.

Shtivelband's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 541 traditional Medicare patients, billed 215,560 HCPCS/CPT codes, and received $3,277,824 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,887 prescription claims across 305 beneficiaries totaling $3,391,208 in drug costs, led by Pomalyst (Pomalidomide). 2021 DME data shows 25 claims. Open Payments data shows 67 records totaling $694,259. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,700,200 to $3,391,208. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	563	228,355	$2,078,865
2016	572	219,228	$2,113,743
2017	571	224,455	$2,572,917
2018	561	224,127	$2,800,263
2019	548	211,324	$2,369,137
2020	515	178,848	$2,130,678
2021	450	142,124	$2,205,642
2022	430	137,756	$2,118,118
2023	450	146,595	$2,519,843
2024	541	215,560	$3,277,824

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	329	2,599	$1,700,200
2016	328	2,848	$2,343,978
2017	306	2,294	$2,042,702
2018	282	2,093	$2,373,231
2019	263	1,679	$2,393,090
2020	247	1,468	$2,672,514
2021	252	1,429	$2,584,784
2022	234	1,217	$2,448,039
2023	254	1,302	$2,102,699
2024	305	1,887	$3,391,208

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	49	$37,929
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	25	$1,430
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	72	441	$96
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	63	63	$79
99442	Telephone medical discussion with physician, 11-20 minutes	67	112	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	413	1,002	$64
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	50	202	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	29	812	$699,003
Xtandi	Enzalutamide	40	1,166	$572,853
Revlimid	Lenalidomide	21	532	$343,701
Lenalidomide	Lenalidomide	28	721	$313,014
Venclexta	Venetoclax	21	622	$261,225

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	57	$1,065	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$693,195	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mikhail I. Shtivelband, MD?

Tedicare shows public-source Medicare data for Mikhail I. Shtivelband, MD (NPI 1740254473), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mikhail I. Shtivelband, MD have ACO affiliation data?

Mikhail I. Shtivelband, MD is shown with ACO affiliation data for Arizona Care Network (MSSP, ACO ID A5176) and Commonwealth Primary Care ACO LLC (REACH, ACO ID D0224).

What billing organization is linked to Mikhail I. Shtivelband, MD?

Mikhail I. Shtivelband, MD is linked to IRONWOOD PHYSICIANS, PC (billing NPI 1740269299) in the available physician profile data.

Does Mikhail I. Shtivelband, MD have Open Payments data?

Mikhail I. Shtivelband, MD has 67 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.